🇮🇳 Dr Reddys Laboratories Ltd

Press Release 05-11-2026 09:47:25 IST

Overview: Brazil's ANVISA granted marketing authorization for Dr. Reddy’s generic semaglutide injection for treating adults with type 2 diabetes mellitus.

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest